Koers Boji Medical Technology Co.,Ltd.
Aandelen
300404
CNE100001Y00
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,31 CNY | +0,55% | +8,62% | -18,32% |
Omzet 2022 | 424 mln. 58,47 mln. 54,68 mln. | Omzet 2023 | 556 mln. 76,71 mln. 71,73 mln. | Marktkapitalisatie | 3,42 mld. 472 mln. 441 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 27 mln. 3,73 mln. 3,48 mln. | Nettowinst (verlies) 2023 | 24 mln. 3,31 mln. 3,1 mln. | EV/omzet 2022 | 6,16 x |
Nettoliquiditeiten 2022 | 272 mln. 37,51 mln. 35,07 mln. | Nettoliquiditeiten 2023 | 293 mln. 40,43 mln. 37,8 mln. | EV/omzet 2023 | 5,62 x |
K/w-verhouding 2022 |
104
x | K/w-verhouding 2023 |
136
x | Werknemers | 1.186 |
Dividendrendement 2022 |
0,13% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 58,86% |
1 dag | +0,55% | ||
1 week | +8,62% | ||
Lopende maand | -3,69% | ||
1 maand | -5,31% | ||
3 maanden | -6,76% | ||
6 maanden | -12,66% | ||
Lopend jaar | -18,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Cun Wang
CEO | Chief Executive Officer | 59 | 11-06-11 |
Xiu Qing Ou
DFI | Director of Finance/CFO | 42 | 01-12-03 |
Bo Tan
BRD | Director/Board Member | 42 | 01-10-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting Cun Wang
CEO | Chief Executive Officer | 59 | 11-06-11 |
Yu Ping Han
PRN | Corporate Officer/Principal | 51 | 01-11-08 |
Bo Tan
BRD | Director/Board Member | 42 | 01-10-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 7,31 | +0,55% | 11 867 410 |
25-04-24 | 7,27 | +4,15% | 15 433 440 |
24-04-24 | 6,98 | +1,90% | 5 339 017 |
23-04-24 | 6,85 | +1,48% | 5 612 810 |
22-04-24 | 6,75 | +1,35% | 4 463 566 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,32% | 383 mln. | |
+1,95% | 42,59 mld. | |
+8,23% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,91% | 24,81 mld. | |
-24,48% | 18,17 mld. | |
+28,75% | 12,05 mld. | |
-2,87% | 11,7 mld. | |
+6,75% | 11,1 mld. |